Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

NCT05132972 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
42
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia

Collaborators